ARSENALBIO
Arsenal Biosciences, Inc.
Application Filed: 2021-03-26
Trademark Application Details
FOURTH EXTENSION - GRANTED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 90981124 |
| Mark Drawing Code | 4: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | R. Gwen Peterson |
| Attorney Docket Number | 1244385 |
| Law Office Assigned | M10 |
| Employee Name | WOOD, CAROLINE |
Timeline
| 2021-03-26 | Application Filed |
| 2024-03-21 | Location: INTENT TO USE SECTION |
| 2024-06-25 | Status: Live/Pending |
| 2024-06-25 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Arsenal Biosciences, Inc. |
| Address | 329 Oyster Point Blvd. South San Francisc DE 94080 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Biologics for medical use, namely, biological preparations for the assessment of treatment options for, and the treatment and prophylaxis of, solid tumors and oncological diseases, disorders and conditions; biologics for medical use, namely, immune cell therapies and T-cell preparations for the treatment of solid tumors; biologics for medical use, namely, immune cell therapies and T-cell preparations for the treatment of oncological and infectious diseases, disorders and conditions; biologics for medical use, namely, biologics for the assessment of treatment options for solid tumors; biologics for medical use, namely, biologics for the assessment of treatment options for oncological and infectious diseases, disorders and conditions; biologics for medical purposes, namely, biologics for detecting the presence of malignant diseases, disorders and conditions |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED | 2021-03-30 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2021-07-02 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2021-11-03 | 3 DOCK D:Assigned to Examiner |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2021-11-04 | 4 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2021-11-17 | 5 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2021-12-07 | 6 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2021-12-07 | 7 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2022-02-01 | 8 NOAM E:E-Mail |
| SOU TEAS EXTENSION RECEIVED | 2022-07-27 | 9 EEXT I:Incoming Correspondence |
| SOU EXTENSION 1 FILED | 2022-07-27 | 10 EXT1 S: |
| SOU EXTENSION 1 GRANTED | 2022-07-27 | 11 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-07-29 | 12 EXRA E:E-Mail |
| SOU TEAS EXTENSION RECEIVED | 2023-01-27 | 13 EEXT I:Incoming Correspondence |
| SOU EXTENSION 2 FILED | 2023-01-27 | 14 EXT2 S: |
| SOU EXTENSION 2 GRANTED | 2023-01-27 | 15 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-01-31 | 16 EXRA E:E-Mail |
| SOU TEAS EXTENSION RECEIVED | 2023-07-26 | 17 EEXT I:Incoming Correspondence |
| SOU EXTENSION 3 FILED | 2023-07-26 | 18 EXT3 S: |
| SOU EXTENSION 3 GRANTED | 2023-07-26 | 19 EX3G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-07-28 | 20 EXRA E:E-Mail |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2023-09-27 | 21 COAR I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2023-09-27 | 22 CHAN I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2023-09-27 | 23 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2023-09-27 | 24 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2023-09-27 | 25 TCCA I:Incoming Correspondence |
| SOU TEAS EXTENSION RECEIVED | 2024-01-24 | 26 EEXT I:Incoming Correspondence |
| SOU EXTENSION 4 FILED | 2024-01-24 | 27 EXT4 S: |
| SOU EXTENSION 4 GRANTED | 2024-01-24 | 28 EX4G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2024-01-26 | 29 EXRA E:E-Mail |
| SOU TEAS EXTENSION RECEIVED | 2024-03-01 | 30 EEXT I:Incoming Correspondence |
| TEAS STATEMENT OF USE RECEIVED | 2024-03-01 | 31 EISU I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2024-03-21 | 32 AITU A:Allowance for Publication |
| TEAS REQUEST TO DIVIDE RECEIVED | 2024-03-01 | 33 ERTD I:Incoming Correspondence |
| DIVISIONAL REQUEST RECEIVED | 2024-06-25 | 34 DRRR I:Incoming Correspondence |
| DIVISIONAL PROCESSING COMPLETE | 2024-06-27 | 35 DPCC D:Assigned to Examiner |
| SOU EXTENSION 5 FILED | 2024-03-01 | 36 EXT5 S: |
| SOU EXTENSION 5 GRANTED | 2024-06-27 | 37 EX5G S: |
| USE AMENDMENT FILED | 2024-03-01 | 38 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2024-06-27 | 39 SUPC I:Incoming Correspondence |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2024-06-27 | 40 EXRA E:E-Mail |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2024-08-09 | 41 CNPR P: |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2024-08-09 | 42 SUNA E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 ARSENALBIO 90981124 not registered Live/Pending |
Arsenal Biosciences, Inc. 2021-03-26 |
 ARSENALBIO 90606669 not registered Live/Pending |
Arsenal Biosciences, Inc. 2021-03-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 